03Jul
Committed to Clarity: FDA’s Dedication to Transparency with the End of ASR
On June 21, the Food and Drug Administration (FDA) released a report titled “Statement on agency’s efforts to increase transparency in medical device reporting.” This report describes updates to FDA’s Medical Device Reporting (MDR) Program, namely...
By:
Morrison & Foerster LLP
Related
Oregon employers should be aware of the Oregon Supreme Court’s recent decision in McLaughlin v. Wil...
Read More >
The rapid spread of COVID-19 has disrupted global commerce, destabilized the world’s leading econom...
Read More >
The regulations implementing the Foreign Investment Risk Review Modernization Act of 2018 (FIRRMA), ...
Read More >
On December 13, 2019, a split Eleventh Circuit Court of Appeals (sitting en banc) ruled that several...
Read More >
An empirical analysis of 128 M&A transactions provides food for thought about whether the economic d...
Read More >
The U.S. Department of Labor’s new Wage and Hour Administrator Cheryl Stanton recently released her...
Read More >